Stay updated on Elranatamab in Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Elranatamab in Refractory Multiple Myeloma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe record history now shows Revision: v3.6.3 as the latest version, replacing v3.6.2, signaling a new update to the study record history.SummaryDifference0.1%

- Check15 days agoChange DetectedThe page's revision entry now shows Revision: v3.6.2, replacing the previous v3.6.0, signaling a deployment of a newer page version.SummaryDifference0.1%

- Check29 days agoChange DetectedThe study history now shows enrollment is closed and a new revision tag (v3.6.0) was added, replacing the previous revision (v3.5.5) to reflect an updated version of the record.SummaryDifference0.2%

- Check36 days agoChange DetectedRevision: v3.5.5 replaces v3.5.4 in the page's history, indicating an update to the page's version metadata. This update does not modify the study data or visible content.SummaryDifference0.1%

- Check50 days agoChange DetectedNew entries for Contacts/Locations and Study Status were added to the study history. An older change entry dated 2025-12-02 was removed.SummaryDifference0.3%

- Check57 days agoChange DetectedAn official new revision entry v3.5.4 was added to the study record history. The previous revision v3.5.3 was removed, indicating an update to the record.SummaryDifference0.1%

Stay in the know with updates to Elranatamab in Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.